Skip to main content

Merck Rises, Bristol-Myers Slides Following Cancer Meeting

Shares of Merck are rising this morning, while peer Bristol-Myers is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.